Cagri-Sema (Cagrilintide + Semaglutide) • Month to month

Combining Semaglutide (a GLP-1 receptor agonist) and Cagrilintide (a long-acting amylin analogue). It is being developed for adults with obesity or overweight (with or without type 2 diabetes) and has shown superior weight-loss results